#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypersomnia Metastatic malignant melanoma Cerebellar ataxia Penile cancer Clear cell papillary renal cell carcinoma Myocarditis Oropharyngeal cancer recurrent Trigeminal neuralgia Familial haemophagocytic lymphohistiocytosis Thermal burn Bronchopulmonary dysplasia Myelodysplastic syndrome with excess blasts Asthma Leiomyosarcoma metastatic Hypertriglyceridaemia More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome Alternating hemiplegia of childhood – Life with Disease Hyperoxaluria – Diagnostics Activated PI3 kinase delta syndrome – Life with Disease Angiosarcoma Breast angiosarcoma – Trials in Disease Nodal marginal zone B-cell lymphoma – Basic Information Antisynthetase syndrome – Life with Disease Rhabdomyosarcoma recurrent – Treatment Ewing’s sarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levomepromazine Hydrochloride Ziclumeran Betahistine Dihydrochloride Opevesostat Tosilate Dimeticone Pertuzumab Spartalizumab Bjt-778 Ucart22 PAPAVERINE HYDROCHLORIDE Belatacept Stx-241 Pertechnetate (99Mtc) Sodium MOLNUPIRAVIR CAMOSTAT MESILATE Bepirovirsen HYDROXYCHLOROQUINE Lisocabtagene Maraleucel Palonosetron Dostarlimab More therapies…

    Learn about Your Condition

    Cataract Asthma Alveolar bone defect Urea cycle disorder Cerebral amyloid angiopathy Pancreatic carcinoma T-cell type acute leukaemia Venous thrombosis Benign renal neoplasm Lip and/or oral cavity cancer Neurodegenerative disorder Drug use disorder Biliary adenoma Tympanic membrane hyperaemia B-cell lymphoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universiteit Maastricht

Universiteit Maastricht

Minderbroedersberg 4-6, Maastricht, 6211 LK, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Montelukast for COVID-19 Patients at Higher Risk of Complications in the Community

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Montelukast
    The Netherlands

  • A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Ziltivekimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Study on Montelukast for COVID-19 Patients at Higher Risk in Primary Care

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Montelukast
    The Netherlands

  • Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Nivolumab
    France Italy The Netherlands Poland Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!